Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEPHROCARE HEALTH SERVICES LTD.

NSE : NEPHROPLUSBSE : 544647ISIN CODE : INE428V01029Industry : Hospital & Healthcare ServicesHouse : Private

BSE509.1512.75 (+2.57 %)

PREV CLOSE ( ) 496.40

OPEN PRICE ( ) 495.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 19349

TODAY'S LOW / HIGH ( )495.00 513.20

52 WK LOW / HIGH ( )445 517.5

NSE508.5512.25 (+2.47 %)

PREV CLOSE( ) 496.30

OPEN PRICE ( ) 496.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 508.55 (1362)

VOLUME 276094

TODAY'S LOW / HIGH( ) 496.30 514.00

52 WK LOW / HIGH ( )446 517.85

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Profit Before Tax

874.37

331.61

-85.91

Adjustment

930.40

801.84

685.63

Changes In working Capital

-441.73

-330.02

-533.24

Cash Flow after changes in Working Capital

1363.04

803.43

66.48

Cash Flow from Operating Activities

1353.47

722.80

112.69

Cash Flow from Investing Activities

-1250.73

-506.60

-782.06

Cash Flow from Financing Activities

543.71

267.39

599.66

Net Cash Inflow / Outflow

646.45

483.59

-69.71

Opening Cash & Cash Equivalents

611.51

140.60

185.51

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

0.21

-12.68

24.80

Closing Cash & Cash Equivalent

1258.17

611.51

140.60